+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Clinical Trial Management Market by Type, Delivery Mode, Component, and End User: Global Opportunity Analysis and Industry Forecast, 2021--2030

  • PDF Icon

    Report

  • 233 Pages
  • February 2022
  • Region: Global
  • Allied Analytics LLP
  • ID: 5578210
UP TO OFF until Aug 20th 2022
The global clinical trial management market was valued at $969.4 million in 2020, and is estimated to reach $ 2,810.5 million by 2030, growing at a CAGR of 11.2% from 2021 to 2030.

Clinical trials are usually conducted to test efficacy and safety of any new product ranging from drugs to medical devices. Clinical trial management (CTM) systems utilize different models of simulation and regression to store and interpret vast amount of unstructured data generated during different clinical trials. These systems help maintain and manage clinical trials conducted by different pharmaceutical companies and clinical research organizations. In addition, these systems make it easier to track and monitor participants involved in the trial, site selection, identify & enroll different subjects, and analyze vast amount of data. Analysis of such data helps in deciding safety parameters of products undergoing clinical trial.

Growth of the global clinical trial management market is majorly driven by large demand for novel therapeutic drugs and medical devices drive growth of the market. Moreover, increase in prevalence of chronic diseases, surge in trend of outsourcing of clinical trials, and increase in awareness regarding benefits of using CTM fuels growth of the clinical trial management market. However, high cost associated with CTM and dearth of skilled professionals hamper the market growth.

The global clinical trial management market is segmented on the basis of type, delivery mode, component, and end user, and region. By Type, the market is categorized into enterprise-based and site-based. On the basis of component, it is divided into software and service. By end user, it is divided into pharmaceutical & biopharmaceutical companies, clinical research organizations, and healthcare providers. Region wise, the clinical trial management market is divided into North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the global clinical trial management market include Advarra, Inc., Clario, Deloitte Touche Tohmatsu Limited, IBM Corporation, Medideta Solution Inc., Mednet Solution Inc., Oracle Corporation, PAREXEL International Corporation, Thermo Fisher Scientific, Inc., and Veeva System Inc. Other prominent players in the value chain include Arisglobal, eClinForce Inc., DZS Software Solutions, DSG, Inc., Guger Technologies Inc., ICON, Plc., ChemWare Inc., and iWeb Technologies Limited.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the global clinical trial management market size along with the current trends and future estimations to elucidate the imminent investment pockets
  • It offers market analysis from 2021 to 2030, which is expected to enable stakeholders to capitalize on prevailing opportunities in the market
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global clinical trial management market

KEY MARKET SEGMENTS


By Product

  • Web-based CTMS
  • On-premise

By Product Type

  • Enterprise-based
  • Site-based

By component

  • Software
  • Hardware
  • Services
  • End User
  • Pharmaceutical & Biopharmaceutical Companies
  • Clinical Research Organizations
  • Healthcare Providers

By Region

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Advarra, Inc
  • Clario
  • Deloitte Touche Tohmatsu Limited
  • IBM Corporation
  • Medideta Solution Inc
  • Mednet Solution Inc
  • Oracle Corporation
  • PAREXEL International Corporation
  • Thermo Fisher Scientific, Inc
  • Veeva System Inc

Table of Contents

Chapter 1: Introduction
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Landscape
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power Among Buyers
3.4. Market Share Analysis/Top Player Positioning
3.4.1. Market Share Analysis/Top Player Positioning 2020
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. Covid-19 Impact Analysis
Chapter 4: Clinical Trial Management Market, by Type
4.1. Market Overview
4.1.1Market Size and Forecast, by Type
4.2. Enterprise Based
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Share Analysis, by Country
4.3. Site Based
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Share Analysis, by Country
Chapter 5: Clinical Trial Management Market, by Delivery Mode
5.1. Market Overview
5.1.1Market Size and Forecast, by Delivery Mode
5.2. Web-Based Ctms
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, by Region
5.2.3. Market Share Analysis, by Country
5.3. On-Premise
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, by Region
5.3.3. Market Share Analysis, by Country
5.4. Cloud Based
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, by Region
5.4.3. Market Share Analysis, by Country
Chapter 6: Clinical Trial Management Market, by Component
6.1. Market Overview
6.1.1Market Size and Forecast, by Component
6.2. Software
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, by Region
6.2.3. Market Share Analysis, by Country
6.3. Services
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, by Region
6.3.3. Market Share Analysis, by Country
Chapter 7: Clinical Trial Management Market, by End-users
7.1. Market Overview
7.1.1Market Size and Forecast, by End-users
7.2. Pharmaceutical and Biopharmaceutical Companies
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, by Region
7.2.3. Market Share Analysis, by Country
7.3. Clinical Research Organization
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, by Region
7.3.3. Market Share Analysis, by Country
7.4. Healthcare Providers
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, by Region
7.4.3. Market Share Analysis, by Country
Chapter 8: Clinical Trial Management Market, by Region
8.1. Market Overview
8.1.1Market Size and Forecast, by Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, by Type
8.2.3. Market Size and Forecast, by Delivery Mode
8.2.4. Market Size and Forecast, by Component
8.2.5. Market Size and Forecast, by End-users
8.2.6. Market Size and Forecast, by Country
8.2.7. United States Clinical Trial Management Market
8.2.7.1. Market Size and Forecast, by Type
8.2.7.2. Market Size and Forecast, by Delivery Mode
8.2.7.3. Market Size and Forecast, by Component
8.2.7.4. Market Size and Forecast, by End-users
8.2.8. Canada Clinical Trial Management Market
8.2.8.1. Market Size and Forecast, by Type
8.2.8.2. Market Size and Forecast, by Delivery Mode
8.2.8.3. Market Size and Forecast, by Component
8.2.8.4. Market Size and Forecast, by End-users
8.2.9. Mexico Clinical Trial Management Market
8.2.9.1. Market Size and Forecast, by Type
8.2.9.2. Market Size and Forecast, by Delivery Mode
8.2.9.3. Market Size and Forecast, by Component
8.2.9.4. Market Size and Forecast, by End-users
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, by Type
8.3.3. Market Size and Forecast, by Delivery Mode
8.3.4. Market Size and Forecast, by Component
8.3.5. Market Size and Forecast, by End-users
8.3.6. Market Size and Forecast, by Country
8.3.7. France Clinical Trial Management Market
8.3.7.1. Market Size and Forecast, by Type
8.3.7.2. Market Size and Forecast, by Delivery Mode
8.3.7.3. Market Size and Forecast, by Component
8.3.7.4. Market Size and Forecast, by End-users
8.3.8. Germany Clinical Trial Management Market
8.3.8.1. Market Size and Forecast, by Type
8.3.8.2. Market Size and Forecast, by Delivery Mode
8.3.8.3. Market Size and Forecast, by Component
8.3.8.4. Market Size and Forecast, by End-users
8.3.9. Italy Clinical Trial Management Market
8.3.9.1. Market Size and Forecast, by Type
8.3.9.2. Market Size and Forecast, by Delivery Mode
8.3.9.3. Market Size and Forecast, by Component
8.3.9.4. Market Size and Forecast, by End-users
8.3.10. Spain Clinical Trial Management Market
8.3.10.1. Market Size and Forecast, by Type
8.3.10.2. Market Size and Forecast, by Delivery Mode
8.3.10.3. Market Size and Forecast, by Component
8.3.10.4. Market Size and Forecast, by End-users
8.3.11. U. K Clinical Trial Management Market
8.3.11.1. Market Size and Forecast, by Type
8.3.11.2. Market Size and Forecast, by Delivery Mode
8.3.11.3. Market Size and Forecast, by Component
8.3.11.4. Market Size and Forecast, by End-users
8.3.12. Rest of Europe Clinical Trial Management Market
8.3.12.1. Market Size and Forecast, by Type
8.3.12.2. Market Size and Forecast, by Delivery Mode
8.3.12.3. Market Size and Forecast, by Component
8.3.12.4. Market Size and Forecast, by End-users
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, by Type
8.4.3. Market Size and Forecast, by Delivery Mode
8.4.4. Market Size and Forecast, by Component
8.4.5. Market Size and Forecast, by End-users
8.4.6. Market Size and Forecast, by Country
8.4.7. China Clinical Trial Management Market
8.4.7.1. Market Size and Forecast, by Type
8.4.7.2. Market Size and Forecast, by Delivery Mode
8.4.7.3. Market Size and Forecast, by Component
8.4.7.4. Market Size and Forecast, by End-users
8.4.8. Japan Clinical Trial Management Market
8.4.8.1. Market Size and Forecast, by Type
8.4.8.2. Market Size and Forecast, by Delivery Mode
8.4.8.3. Market Size and Forecast, by Component
8.4.8.4. Market Size and Forecast, by End-users
8.4.9. India Clinical Trial Management Market
8.4.9.1. Market Size and Forecast, by Type
8.4.9.2. Market Size and Forecast, by Delivery Mode
8.4.9.3. Market Size and Forecast, by Component
8.4.9.4. Market Size and Forecast, by End-users
8.4.10. South Korea Clinical Trial Management Market
8.4.10.1. Market Size and Forecast, by Type
8.4.10.2. Market Size and Forecast, by Delivery Mode
8.4.10.3. Market Size and Forecast, by Component
8.4.10.4. Market Size and Forecast, by End-users
8.4.11. Australia Clinical Trial Management Market
8.4.11.1. Market Size and Forecast, by Type
8.4.11.2. Market Size and Forecast, by Delivery Mode
8.4.11.3. Market Size and Forecast, by Component
8.4.11.4. Market Size and Forecast, by End-users
8.4.12. Rest of Asia-Pacific Clinical Trial Management Market
8.4.12.1. Market Size and Forecast, by Type
8.4.12.2. Market Size and Forecast, by Delivery Mode
8.4.12.3. Market Size and Forecast, by Component
8.4.12.4. Market Size and Forecast, by End-users
8.5. Lamea
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, by Type
8.5.3. Market Size and Forecast, by Delivery Mode
8.5.4. Market Size and Forecast, by Component
8.5.5. Market Size and Forecast, by End-users
8.5.6. Market Size and Forecast, by Country
8.5.7. Brazil Clinical Trial Management Market
8.5.7.1. Market Size and Forecast, by Type
8.5.7.2. Market Size and Forecast, by Delivery Mode
8.5.7.3. Market Size and Forecast, by Component
8.5.7.4. Market Size and Forecast, by End-users
8.5.8. South Africa, Clinical Trial Management Market
8.5.8.1. Market Size and Forecast, by Type
8.5.8.2. Market Size and Forecast, by Delivery Mode
8.5.8.3. Market Size and Forecast, by Component
8.5.8.4. Market Size and Forecast, by End-users
8.5.9. Saudi Arabia Clinical Trial Management Market
8.5.9.1. Market Size and Forecast, by Type
8.5.9.2. Market Size and Forecast, by Delivery Mode
8.5.9.3. Market Size and Forecast, by Component
8.5.9.4. Market Size and Forecast, by End-users
8.5.10. Rest of LAMEA Clinical Trial Management Market
8.5.10.1. Market Size and Forecast, by Type
8.5.10.2. Market Size and Forecast, by Delivery Mode
8.5.10.3. Market Size and Forecast, by Component
8.5.10.4. Market Size and Forecast, by End-users
Chapter 9: Company Profiles
9.1. Advarra, Inc
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Clario
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Deloitte Touche Tohmatsu Limited
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Ibm Corporation
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Medideta Solution Inc.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Mednet Solution Inc.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Oracle Corporation
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Parexel International Corporation
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Thermo Fisher Scientific, Inc
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Veeva System Inc
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
List of Tables
Table 1. Global Clinical Trial Management Market, by Type, 2020-2030 ($Million)
Table 2. Global Clinical Trial Management Market for Enterprise Based, by Region, 2020-2030 ($Million)
Table 3. Global Clinical Trial Management Market for Site Based, by Region, 2020-2030 ($Million)
Table 4. Global Clinical Trial Management Market, by Delivery Mode, 2020-2030 ($Million)
Table 5. Global Clinical Trial Management Market for Web-Based Ctms, by Region, 2020-2030 ($Million)
Table 6. Global Clinical Trial Management Market for On-Premise, by Region, 2020-2030 ($Million)
Table 7. Global Clinical Trial Management Market for Cloud Based, by Region, 2020-2030 ($Million)
Table 8. Global Clinical Trial Management Market, by Component, 2020-2030 ($Million)
Table 9. Global Clinical Trial Management Market for Software, by Region, 2020-2030 ($Million)
Table 10. Global Clinical Trial Management Market for Services, by Region, 2020-2030 ($Million)
Table 11. Global Clinical Trial Management Market, by End-users, 2020-2030 ($Million)
Table 12. Global Clinical Trial Management Market for Pharmaceutical and Biopharmaceutical Companies, by Region, 2020-2030 ($Million)
Table 13. Global Clinical Trial Management Market for Clinical Research Organization, by Region, 2020-2030 ($Million)
Table 14. Global Clinical Trial Management Market for Healthcare Providers, by Region, 2020-2030 ($Million)
Table 15. Global Clinical Trial Management Market, by Region, 2020-2030 ($Million)
Table 16. North America Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 17. North America Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 18. North America Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 19. North America Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 20. United States Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 21. United States Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 22. United States Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 23. United States Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 24. Canada Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 25. Canada Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 26. Canada Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 27. Canada Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 28. Mexico Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 29. Mexico Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 30. Mexico Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 31. Mexico Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 32. Europe Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 33. Europe Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 34. Europe Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 35. Europe Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 36. France Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 37. France Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 38. France Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 39. France Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 40. Germany Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 41. Germany Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 42. Germany Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 43. Germany Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 44. Italy Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 45. Italy Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 46. Italy Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 47. Italy Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 48. Spain Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 49. Spain Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 50. Spain Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 51. Spain Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 52. United Kingdom Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 53. United Kingdom Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 54. United Kingdom Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 55. United Kingdom Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 56. Rest of Europe Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 57. Rest of Europe Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 58. Rest of Europe Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 59. Rest of Europe Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 60. Asia-Pacific Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 61. Asia-Pacific Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 62. Asia-Pacific Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 63. Asia-Pacific Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 64. China Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 65. China Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 66. China Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 67. China Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 68. Japan Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 69. Japan Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 70. Japan Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 71. Japan Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 72. India Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 73. India Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 74. India Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 75. India Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 76. South Korea Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 77. South Korea Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 78. South Korea Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 79. South Korea Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 80. Australia Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 81. Australia Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 82. Australia Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 83. Australia Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 84. Rest of Asia-Pacific Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 85. Rest of Asia-Pacific Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 86. Rest of Asia-Pacific Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 87. Rest of Asia-Pacific Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 88. Lamea Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 89. Lamea Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 90. Lamea Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 91. Lamea Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 92. Brazil Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 93. Brazil Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 94. Brazil Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 95. Brazil Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 96. South Africa, Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 97. South Africa, Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 98. South Africa, Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 99. South Africa, Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 100. Saudi Arabia Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 101. Saudi Arabia Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 102. Saudi Arabia Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 103. Saudi Arabia Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 104. Rest of LAMEA Clinical Trial Management, by Type, 2020-2030 ($Million)
Table 105. Rest of LAMEA Clinical Trial Management, by Delivery Mode, 2020-2030 ($Million)
Table 106. Rest of LAMEA Clinical Trial Management, by Component, 2020-2030 ($Million)
Table 107. Rest of LAMEA Clinical Trial Management, by End-users, 2020-2030 ($Million)
Table 108. Advarra, Inc: Key Executives
Table 109. Advarra, Inc: Company Snapshot
Table 110. Advarra, Inc: Operating Segments
Table 111. Advarra, Inc: Product Portfolio
Table 112. Advarra, Inc: Key Strategic Moves and Developments
Table 113. Clario: Key Executives
Table 114. Clario: Company Snapshot
Table 115. Clario: Operating Segments
Table 116. Clario: Product Portfolio
Table 117. Clario: Key Strategic Moves and Developments
Table 118. Deloitte Touche Tohmatsu Limited: Key Executives
Table 119. Deloitte Touche Tohmatsu Limited: Company Snapshot
Table 120. Deloitte Touche Tohmatsu Limited: Operating Segments
Table 121. Deloitte Touche Tohmatsu Limited: Product Portfolio
Table 122. Deloitte Touche Tohmatsu Limited: Key Strategic Moves and Developments
Table 123. Ibm Corporation: Key Executives
Table 124. Ibm Corporation: Company Snapshot
Table 125. Ibm Corporation: Operating Segments
Table 126. Ibm Corporation: Product Portfolio
Table 127. Ibm Corporation: Key Strategic Moves and Developments
Table 128. Medideta Solution Inc. : Key Executives
Table 129. Medideta Solution Inc. : Company Snapshot
Table 130. Medideta Solution Inc. : Operating Segments
Table 131. Medideta Solution Inc. : Product Portfolio
Table 132. Medideta Solution Inc. : Key Strategic Moves and Developments
Table 133. Mednet Solution Inc. : Key Executives
Table 134. Mednet Solution Inc. : Company Snapshot
Table 135. Mednet Solution Inc. : Operating Segments
Table 136. Mednet Solution Inc. : Product Portfolio
Table 137. Mednet Solution Inc. : Key Strategic Moves and Developments
Table 138. Oracle Corporation: Key Executives
Table 139. Oracle Corporation: Company Snapshot
Table 140. Oracle Corporation: Operating Segments
Table 141. Oracle Corporation: Product Portfolio
Table 142. Oracle Corporation: Key Strategic Moves and Developments
Table 143. Parexel International Corporation: Key Executives
Table 144. Parexel International Corporation: Company Snapshot
Table 145. Parexel International Corporation: Operating Segments
Table 146. Parexel International Corporation: Product Portfolio
Table 147. Parexel International Corporation: Key Strategic Moves and Developments
Table 148. Thermo Fisher Scientific, Inc: Key Executives
Table 149. Thermo Fisher Scientific, Inc: Company Snapshot
Table 150. Thermo Fisher Scientific, Inc: Operating Segments
Table 151. Thermo Fisher Scientific, Inc: Product Portfolio
Table 152. Thermo Fisher Scientific, Inc: Key Strategic Moves and Developments
Table 153. Veeva System Inc: Key Executives
Table 154. Veeva System Inc: Company Snapshot
Table 155. Veeva System Inc: Operating Segments
Table 156. Veeva System Inc: Product Portfolio
Table 157. Veeva System Inc: Key Strategic Moves and Developments
List of Figures
Figure 1. Global Clinical Trial Management Market Segmentation
Figure 2. Global Clinical Trial Management Market
Figure 3. Segmentation Clinical Trial Management Market
Figure 4. Top Investment Pocket in Clinical Trial Management Market
Figure 5. Top Winning Strategies, 2019-2021*
Figure 6. Top Winning Strategies, by Development, 2019-2021(%)
Figure 7. Top Winning Strategies, by Company, 2019-2021*
Figure 8. Moderate Bargaining Power of Buyers
Figure 9. Moderate Bargaining Power of Suppliers
Figure 10. Moderate Threat of New Entrants
Figure 11. Low Threat of Substitution
Figure 12. High Competitive Rivalry
Figure 13. Top Player Positioning, 2020
Figure 14. Market Share Analysis, 2020
Figure 15. Restraints and Drivers: Clinical Trial Management Market
Figure 16. Clinical Trial Management Market Segmentation, by Type
Figure 17. Clinical Trial Management Market for Enterprise Based, by Country, 2020-2030 ($ Million)
Figure 18. Clinical Trial Management Market for Site Based, by Country, 2020-2030 ($ Million)
Figure 19. Clinical Trial Management Market Segmentation, by Delivery Mode
Figure 20. Clinical Trial Management Market for Web-Based Ctms, by Country, 2020-2030 ($ Million)
Figure 21. Clinical Trial Management Market for On-Premise, by Country, 2020-2030 ($ Million)
Figure 22. Clinical Trial Management Market for Cloud Based, by Country, 2020-2030 ($ Million)
Figure 23. Clinical Trial Management Market Segmentation, by Component
Figure 24. Clinical Trial Management Market for Software, by Country, 2020-2030 ($ Million)
Figure 25. Clinical Trial Management Market for Services, by Country, 2020-2030 ($ Million)
Figure 26. Clinical Trial Management Market Segmentation, by End-users
Figure 27. Clinical Trial Management Market for Pharmaceutical and Biopharmaceutical Companies, by Country, 2020-2030 ($ Million)
Figure 28. Clinical Trial Management Market for Clinical Research Organization, by Country, 2020-2030 ($ Million)
Figure 29. Clinical Trial Management Market for Healthcare Providers, by Country, 2020-2030 ($ Million)
Figure 30. Advarra, Inc: Net Sales, 2018-2020 ($ Million)
Figure 31. Advarra, Inc: Revenue Share, by Segment, 2020 (%)
Figure 32. Advarra, Inc: Revenue Share, by Region, 2020 (%)
Figure 33. Clario: Net Sales, 2018-2020 ($ Million)
Figure 34. Clario: Revenue Share, by Segment, 2020 (%)
Figure 35. Clario: Revenue Share, by Region, 2020 (%)
Figure 36. Deloitte Touche Tohmatsu Limited: Net Sales, 2018-2020 ($ Million)
Figure 37. Deloitte Touche Tohmatsu Limited: Revenue Share, by Segment, 2020 (%)
Figure 38. Deloitte Touche Tohmatsu Limited: Revenue Share, by Region, 2020 (%)
Figure 39. Ibm Corporation: Net Sales, 2018-2020 ($ Million)
Figure 40. Ibm Corporation: Revenue Share, by Segment, 2020 (%)
Figure 41. Ibm Corporation: Revenue Share, by Region, 2020 (%)
Figure 42. Medideta Solution Inc: Net Sales, 2018-2020 ($ Million)
Figure 43. Medideta Solution Inc: Revenue Share, by Segment, 2020 (%)
Figure 44. Medideta Solution Inc: Revenue Share, by Region, 2020 (%)
Figure 45. Mednet Solution Inc: Net Sales, 2018-2020 ($ Million)
Figure 46. Mednet Solution Inc: Revenue Share, by Segment, 2020 (%)
Figure 47. Mednet Solution Inc: Revenue Share, by Region, 2020 (%)
Figure 48. Oracle Corporation: Net Sales, 2018-2020 ($ Million)
Figure 49. Oracle Corporation: Revenue Share, by Segment, 2020 (%)
Figure 50. Oracle Corporation: Revenue Share, by Region, 2020 (%)
Figure 51. Parexel International Corporation: Net Sales, 2018-2020 ($ Million)
Figure 52. Parexel International Corporation: Revenue Share, by Segment, 2020 (%)
Figure 53. Parexel International Corporation: Revenue Share, by Region, 2020 (%)
Figure 54. Thermo Fisher Scientific, Inc: Net Sales, 2018-2020 ($ Million)
Figure 55. Thermo Fisher Scientific, Inc: Revenue Share, by Segment, 2020 (%)
Figure 56. Thermo Fisher Scientific, Inc: Revenue Share, by Region, 2020 (%)
Figure 57. Veeva System Inc: Net Sales, 2018-2020 ($ Million)
Figure 58. Veeva System Inc: Revenue Share, by Segment, 2020 (%)
Figure 59. Veeva System Inc: Revenue Share, by Region, 2020 (%)

Executive Summary

According to a new report titled, “Clinical Trial Management Market by type, delivery mode, component and end user: global opportunity analysis and industry forecast, 2021–2030,the global clinical trial management market was valued at $969.4 million in 2020, and is estimated to reach $2,810.5 million by 2030, growing at a CAGR of 11.2% from 2021 to 2030.

Clinical trial management system (CTMS) helps in maintenance and management of vast and highly complex data obtained from clinical trials. The system aims to track clinical trial occurring in different parts of the world and the data can be analyzed routinely through multiple regression, simulation, and other models. In addition, use of clinical trial management systems helps to optimize time management and enhance connectivity and reduce communication gap between researchers and their investors.

Surge in trend of outsourcing of clinical trials and rise in number of clinical trials, owing to high demand for novel therapeutic drugs and medical devices propels the market growth. Moreover, increase in prevalence of chronic diseases and increase in awareness regarding the benefits of using CTM further fuel growth of the clinical trial management market. In addition, rise in expenditure and number of R&D activities by various pharmaceutical companies also help increase in demand for clinical trial management systems. However, high cost associated with CTM and lack of skilled professionals is projected to hamper the market growth.

By component, the software segment was the dominant segment in the CTM market, owing to availability of advanced software that improves efficiency and productivity of researchers. The web-based segment had the largest share of the global CTMS market, owing to advantages such as enhanced quality and productivity of clinical trials, better time management, and ease of access. Enterprise-based system was the dominant segment contributing toward the market growth. However, site-based is expected to be the fastest growing segment as they are easier to use. The pharmaceutical & biopharmaceutical segment was the dominant segment, owing to large number of clinical trials conducted for development of novel therapeutic drugs and medical devices.

The global clinical trial management market is segmented on the basis of type, delivery mode, component, and end user, and region. By type, the market is categorized into enterprise-based and site-based. On the basis of component, it is divided into software and service. By end user, it is divided into pharmaceutical & biopharmaceutical companies, clinical research organizations, and healthcare providers. Region wise, the clinical trial management market is divided into North America, Europe, Asia-Pacific, and LAMEA

The COVID-19 outbreak is anticipated to have a negative impact on growth of the global clinical trial management market. Focus on developing a novel vaccine and treatment for COVID-19 disrupted upcoming and ongoing clinical trials on other diseases around the globe. According to the Journal of International Nepal Epidemiological Association, in 2020, it was reported that the ability to conduct ongoing clinical trials during COVID-19 pandemic has affected 69% of respondents.

Key Findings Of The Study


  • By type, the enterprise-based segment was the highest contributor to the market in 2020
  • By delivery mode, the web-based segment was the highest contributor to the market in 2020
  • On the basis of component, the software segment dominated the market in 2020
  • Depending on end user, the pharmaceutical & biopharmaceutical segment dominated the market in 2020
  • Region wise, North America garnered the largest revenue share in 2020, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
  • North America garnered a major share of the clinical trial management market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in chronic diseases, advancements in technologies in clinical trial management systems, and increase in ability to safeguard developments in medical practices propel growth of the clinical trial management system industry However, Asia-Pacific is expected to register highest CAGR of 134% from 2021 to 2030, owing to advancements in R&D activities in the pharmaceutical industry, increasing chronic diseases, and rise in disposable income

Companies Mentioned

  • Advarra, Inc.
  • Clario
  • Deloitte Touche Tohmatsu Limited
  • IBM Corporation
  • Medideta Solution Inc.
  • Mednet Solution Inc.
  • Oracle Corporation
  • PAREXEL International Corporation
  • Thermo Fisher Scientific, Inc.
  • Veeva System Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...